Related Experiment Videos
T-cell control by human T-cell leukemia/lymphoma virus type 1
Genoveffa Franchini1, Risaku Fukumoto, Jake R Fullen
1Basic Research Laboratory, National Cancer Institute, Bethesda, Maryland 20892-5055, USA. franchig@mail.nih.gov
International Journal of Hematology
|December 23, 2003
Summary
Human T-cell leukemia/lymphoma virus type 1 (HTLV-1) drives T-cell cancer by hijacking cell signaling pathways. This review explores viral mechanisms and T-cell responses contributing to adult T-cell leukemia/lymphoma development.
Area of Science:
- Virology
- Immunology
- Oncology
Background:
- Human T-cell leukemia/lymphoma virus type 1 (HTLV-1) is linked to adult T-cell leukemia/lymphoma (ATLL).
- Viral proteins manipulate T-cell functions, promoting survival and proliferation.
Purpose of the Study:
- To review mechanisms of HTLV-1 replication.
- To examine T-cell pathways usurped by HTLV-1.
- To correlate in vitro findings with in vivo oncogenesis.
Main Methods:
- In vitro studies of viral protein functions.
- Analysis of T-cell signaling pathways.
- Review of epidemiological and genetic data.
Main Results:
- HTLV-1 proteins enhance T-cell responsiveness to stimulation.
- Viral proteins modulate apoptosis and immune recognition.
- HTLV-1 usurps signaling pathways to promote T-cell proliferation.
Conclusions:
- HTLV-1 oncogenesis involves viral proteins, T-cell signaling, and host factors.
- Understanding viral mechanisms is key to combating ATLL.
- Extracellular signals and chronic stimulation may contribute to disease.